AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimixia-M F 1 Tablet

Prescription Icon
Prescription Required

Marketer

Wings Biotech Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Glimixia-M F 1 Tablet

Diabex Duo, a dual-action antidiabetic medication, is prescribed for adult patients with type 2 diabetes. This formulation helps regulate blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan involving diet, exercise, and weight management as recommended by your doctor. Commonly, Diabex Duo may cause hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms – sweating, dizziness, headache, tremors – and appropriate countermeasures. Regular meals and carrying readily available glucose (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician before use. Pregnant or lactating women require medical consultation prior to initiating treatment. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimixia-M F 1 Tablet

Managing type 2 diabetes

Major Benefits of Glimixia-M F 1 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without crushing, chewing, or breaking it. Consume Glimixia-M F 1 Tablet with food.

Common Side effects of Glimixia-M F 1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimixia-M F 1 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimixia-M F 1 Tablet with a meal.

How Glimixia-M F 1 Tablet works:

Glimixia-M F, a single tablet formulation, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea derivative, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimixia-M F 1 Tablet with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimixia-M F 1 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimixia-M F 1 Tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimixia-M F 1 Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimixia-M F 1 Tablets cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is usually prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimixia-M F 1 Tablet :

Should you forget a Glimixia-M F 1 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimixia-M F 1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimixia-M F 1 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimixia-M F 1 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimixia-M F 1 Tablets and seek immediate medical attention.
Glimixia-M F 1 Tablet combines glimepiride and metformin to treat type 2 diabetes mellitus in adults. It improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glimixia-M F 1 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimixia-M F 1 Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may cause anemia, neurological issues like tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Glimixia-M F 1 Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimixia-M F 1 Tablet with alcohol is unsafe. Alcohol consumption can further reduce blood sugar, risking hypoglycemia, and may heighten the risk of lactic acidosis.
Glimixia-M F 1 Tablet
43
MRP 50
14% off